Recordati stock trades at EUR 52.98 on 9.1 times average volume

Published on 10/09/2026 at 15:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Recordati stock costs EUR 52.98 on October 9, 2026 versus EUR 53.03. Earnings are due November 10, 2026 and P/E is 22.3.

Key points in brief

Recordati stock was trading at EUR 52.98 at Lang & Schwarz on October 9, 2026, down 0.09 percent from EUR 53.03.
Volume was 9.09 times the average level in the October 8 quote.
The stock was 2.70 percent below its EUR 54.45 52-week high as of September 29, 2026.
Recordati's next earnings date is November 10, 2026, while its trailing P/E was 22.3.

Moderne Pharma-Produktionsanlage mit Edelstahltanks und Glasfassade bei Tageslicht — Recordati S.p.A. (IT0003828271) betreibt moderne Pharma-Produktionsanlagen mit hochwertiger Fertigungstechnik am Firmensitz in Mailand, Italien, Illustration mit AI erstellt.

Recordati stock (ISIN IT0003828271) was trading at EUR 52.98 at Lang & Schwarz on October 9, 2026 at 3:42 p.m. CEST, down 0.09 percent versus the prior close of EUR 53.03. Trading volume was 100 shares against an average of 11 shares in the October 8 quote, equal to 9.09 times the average level.

Price stays near yearly high

The stock remains 2.70 percent below its 52-week high of EUR 54.45 and 20.57 percent above its 52-week low of EUR 43.76, according to InvestPane as of September 29, 2026. The same page lists a 52-week change of 2.80 percent, placing the current quote close to the upper end of that recorded range.

InvestPane lists Recordati at a market capitalization of EUR 10.9 billion, a trailing P/E ratio of 22.3 and a dividend yield of 2.67 percent as of September 29, 2026. The valuation figures give the price report a different frame from the takeover timetable, because the share price is being measured against both earnings and the offer-related trading range.

Comparison with peers

Recordati: minus 0.09 percent, P/E 22.3, market capitalization EUR 10.9 billion

AstraZeneca (Nasdaq, USD): plus 0.53 percent, P/E 23.88, market capitalization USD 247.6 billion

Novartis (NYSE, USD): plus 0.34 percent, P/E 21.92, market capitalization USD 272.9 billion

Calendar keeps November date

InvestPane lists November 10, 2026 as Recordati's next earnings date. The investor page describes the company as a pharmaceutical group listed on the Italian stock exchange, with more than 4,700 employees and operations in around 150 countries, according to Recordati.

On October 6, 2026, Il Sole 24 ORE reported that Banca Akros cited a EUR 65 target, while Equita cited EUR 69 and Intermonte EUR 71. Those targets sit above the EUR 52.98 Lang & Schwarz price, but each belongs to a dated analyst view rather than to the current market quote.

Lang & Schwarz quote

Recordati was trading at EUR 52.98 at Lang & Schwarz on October 9, 2026 at 3:42 p.m. CEST, down 0.09 percent versus the prior close of EUR 53.03. The further course of trading is shown by the continuously updated real-time quote of Recordati stock.